
from creditors to repay debts and companies on time. However, the delaying of changes to the reimbursement list to January 2014 and a low ceiling for pharmaceutical expenditure will moderate pharmaceutical growth of patented and prescription medicines in 2014. These issues continue to weigh down the analyst´s assessment of Romania´s Pharmaceutical and Healthcare Risk/Reward Ratings into Q114.

Pharmaceuticals: RON13.55bn (US$3.91bn) in 2012 to RON13.96bn (US$4.20bn) in 2013; +3.0% in local currency terms and +7.5% in US dollar terms. US dollar forecast down from Q413 due to leu appreciation.

Healthcare: RON34.02bn (US$9.81bn) in 2012 to RON36.36bn (US$10.94bn) in 2013; +6.9% in local currency terms and +11.5% in US dollar terms. Forecast changed from Q413 due to appreciation in leu.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-an ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-an ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-an ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Re ..

Companiesandmarkets.com aims to provide clients with the widest array of reports and market research across all of our 27 industry sectors. Companiesandmarkets.com âs team of analysts are available to offer clients specific advice on finding relevant information and also purchasing the correct market research reports for their specific business needs. Over 100,000 companies are listed in Companiesandmarkets.com ´s online reports database, providing clients with an extensive coverage not only of company profiles but also of high value and insightful market reports.

Disclaimer: If you have any questions regarding information in this article please contact the author. Please do not contact Live-PR.com. We are not able to assist you. Live-PR.com disclaims content contained in this article. Live-PR.com is not authorized to give any information about content and not responsible for content posted by third party.
